How much funding has Allander Biotechnologies raised?

Allander Biotechnologies has disclosed $1M raised across 1 round.

Where is Allander Biotechnologies headquartered?

Allander Biotechnologies is headquartered in Aurora, US.

Allander Biotechnologies

Aurora, US · Founded 2023 · Delaware corporation

Allander Biotechnologies is a biotechnology company. The page lists leadership roles but provides no usable detail about the company's products or focus.

Biotech

Founders & leadership

Bing ZhaoNamed on SEC filing

XiaoJing WangNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$1M disclosed across 1 round · 2023

▶$1MraisedOct 2023 · 2 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Bing ZhaoDirector
XiaoJing WangExecutive Officer, Director

Offering amount: $1M
Amount sold: $1M
First sale: Oct 2023
Incorporated: Corporation, Delaware, 2023
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap

Bioworld5 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Aro Biotherapeutics5 shared keywordsAro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins. The company builds a wholly-owned pipeline of Centyrin-based therapeutic candidates and partners with industry to enable tissue-specific targeting of therapeutics across a range of diseases.

Cerecor Inc.5 shared keywordsAvalo is a clinical-stage biotechnology company developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases. Its pipeline includes abdakibart (AVTX-009), tested in a Phase 2 trial for hidradenitis suppurativa, and AVTX-010, a long-acting next-generation anti-IL-1β antibody.

Allogene Therapeutics5 shared keywordsAllogene Therapeutics develops allogeneic CAR T cell therapies (AlloCAR T) for blood cancers, solid tumors, and autoimmune diseases, using off-the-shelf manufactured cell products rather than patient-derived autologous approaches. The company aims to expand CAR T treatment access through scalable manufacturing, lower costs, and faster treatment delivery.

Companies competing with Allander Biotechnologies for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Allander Biotechnologies do?: Allander Biotechnologies is a biotechnology company. The page lists leadership roles but provides no usable detail about the company's products or focus.
How much funding has Allander Biotechnologies raised?: Allander Biotechnologies has disclosed $1M raised across 1 round.
Where is Allander Biotechnologies headquartered?: Allander Biotechnologies is headquartered in Aurora, US.